Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)

Market Cap	159.74B -53.5%
Revenue (ttm)	59.34B -32.3%
Net Income	-32.42B
EPS	-654.88
Shares Out	60.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	310,941
Average Volume	605,537
Open	2,730.00
Previous Close	2,735.00
Day's Range	2,565.00 - 2,730.00
52-Week Range	2,565.00 - 8,800.00
Beta	n/a
RSI	33.48
Earnings Date	Apr 3, 2026

About Vivozon Pharmaceutical

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps for offices, houses, apartments, buildings, factories, and parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps. The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon P...

• Founded: 2002
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 082800

Financial Performance

In 2025, Vivozon Pharmaceutical's revenue was 59.34 billion, a decrease of -32.26% compared to the previous year's 87.60 billion. Losses were -32.42 billion, 224.8% more than in 2024.